Markets:

Overview

News

Currencies

International

Treasuries

Moleculin Biotech, Inc. - Common Stock (NQ:MBRX)

0.4101 -0.0149 (-3.51%)

Streaming Delayed Price Updated: 11:29 AM EDT, Aug 4, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Moleculin Biotech, Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >

Earnings Scheduled For August 11, 2023 ↗

August 11, 2023

Companies Reporting Before The Bell • Consolidated Water Co (NASDAQ:CWCO) is estimated to report quarterly earnings at $0.22 per share on revenue of $30.27 million.

Via Benzinga

Earnings Preview For Moleculin Biotech ↗

August 10, 2023

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

July 24, 2023

Via Benzinga

Why Progressive Shares Are Trading Lower By 12%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

July 13, 2023

Gainers

Via Benzinga

MBRX Stock Earnings: Moleculin Biotech Misses EPS Estimates ↗

May 11, 2023

MBRX stock earnings for Q1 show Moleculin Biotech reporting a wider per-share loss than analysts expected.

Via InvestorPlace

Stocks That Hit 52-Week Lows On Thursday ↗

June 15, 2023

On Thursday, 64 companies achieved new lows for the year.

Via Benzinga

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

June 01, 2023

Via Benzinga

Moleculin Biotech: Q1 Earnings Insights ↗

May 11, 2023

Via Benzinga

Moleculin Biotech's Earnings: A Preview ↗

May 10, 2023

Via Benzinga

Earnings Outlook For Moleculin Biotech ↗

March 21, 2023

Via Benzinga

Moleculin Biotech's Potential Antiviral Compound Selected For NIAID-Funded Animal Studies ↗

September 27, 2022

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday ↗

May 05, 2023

Good morning! We're diving into the biggest pre-market stock movers traders will want to keep an eye on for Friday morning!

Via InvestorPlace

What's Going On With Moleculin Biotech Stock Today? ↗

April 18, 2023

Moleculin Biotech Inc (NASDAQ: MBRX) announced that preclinical data regarding its next-generation anthracycline, Annamycin, was presented at the American Association for Cancer Research (AACR) Annual...

Via Benzinga

Moleculin Reveals Final Topline Data From European Study Of Annamycin In Leukemia Setting ↗

February 13, 2023

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday ↗

February 06, 2023

We're starting off the week with an overview of the biggest pre-market stock movers traders need to know about for Monday!

Via InvestorPlace

JTC Team to Host the Virtual Investor 2023 Companies to Watch Event on January 17th, 18th, and 19th

January 11, 2023

Via ACCESSWIRE

12 Health Care Stocks Moving In Monday's After-Market Session ↗

January 02, 2023

Via Benzinga

Moleculin Biotech's Annamycin In Leukemia Study Shows 80% Overall Response Rate ↗

December 15, 2022

Via Benzinga

12 Health Care Stocks Moving In Friday's After-Market Session ↗

December 09, 2022

Via Benzinga

Celularity, Moleculin Biotech And 2 Other Penny Stocks Insiders Are Aggressively Buying ↗

November 29, 2022

The Dow Jones closed lower by around 500 points on Monday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern...

Via Benzinga

Why Drive Shack Shares Jumped Over 23%; Here Are 76 Biggest Movers From Yesterday ↗

November 22, 2022

Gainers Imago BioSciences, Inc. (NASDAQ: IMGO) shares climbed 104.5% to close at $35.59 on Monday after Merck announced it would acquire the company for $36 per share in cash.

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

October 19, 2022

Gainers ASLAN Pharma (NASDAQ:ASLN) stock moved upwards by 13.7% to $0.54 during Wednesday's after-market session. The market value of their outstanding shares is at $37.6 million.

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

September 21, 2022

Gainers Scopus BioPharma (NASDAQ:SCPS) stock moved upwards by 10.9% to $0.3 during Wednesday's pre-market session. The market value of their outstanding shares is at $6.3 million.

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

September 14, 2022

Gainers Enochian BioSciences (NASDAQ:ENOB) shares moved upwards by 27.8% to $2.3 during Wednesday's after-market session. The market value of their outstanding shares is at $121.7 million.

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

August 26, 2022

Via Benzinga

12 Health Care Stocks Moving In Monday's After-Market Session ↗

August 22, 2022

Gainers ABVC BioPharma (NASDAQ:ABVC) shares increased by 12.8% to $0.97 during Monday's after-market session. The company's market cap stands at $31.6 million.

Via Benzinga

Recap Of Friday's Biotech Catalysts - End Of the Day Summary ↗

August 19, 2022

Via Benzinga

Moleculin Biotech Doses Healthy Volunteers For Covid-19 In Early-Stage Study Of WP1122 ↗

May 26, 2022

Moleculin Biotech, Inc. (NASDAQ: MBRX) announced dosing of subjects in its Phase 1a clinical study of WP1122 in healthy volunteers for the treatment of COVID-19.

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗

May 18, 2022

We're getting ready for another full day of trading with a breakdown of the biggest pre-market stock movers for Wednesday!

Via InvestorPlace

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday ↗

May 17, 2022

Good morning, investor! It's time for another busy day of trading as we dive into the biggest pre-market stock movers for Tuesday!

Via InvestorPlace

< Previous 1 2 3 4 5 6 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.